Prestwich R - Search Results

1

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice.

Figen M, Çolpan Öksüz D, Duman E, Prestwich R, Dyker K, Cardale K, Ramasamy S, Murray P, Şen M. Figen M, et al. Among authors: prestwich r. Front Oncol. 2020 Nov 12;10:579917. doi: 10.3389/fonc.2020.579917. eCollection 2020. Front Oncol. 2020. PMID: 33282734 Free PMC article.

2

Improving the therapeutic ratio in head and neck cancer.

Prestwich R, Dyker K, Sen M. Prestwich R, et al. Lancet Oncol. 2010 Jun;11(6):512-3. doi: 10.1016/S1470-2045(10)70060-7. Lancet Oncol. 2010. PMID: 20522378 No abstract available.

3

Functional imaging for head and neck cancer.

Prestwich RJ, Scarsbrook AF, Carey B, Sen M. Prestwich RJ, et al. Lancet Oncol. 2010 Oct;11(10):921-2. doi: 10.1016/S1470-2045(10)70169-8. Lancet Oncol. 2010. PMID: 20932491 No abstract available.

4

The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.

Kancherla KN, Oksuz DC, Prestwich RJ, Fosker C, Dyker KE, Coyle CC, Sen M. Kancherla KN, et al. Among authors: prestwich rj. Clin Oncol (R Coll Radiol). 2011 Mar;23(2):141-8. doi: 10.1016/j.clon.2010.09.006. Epub 2010 Oct 8. Clin Oncol (R Coll Radiol). 2011. PMID: 20934860

5

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer.

Prestwich RJ, Kancherla K, Oksuz DC, Williamson D, Dyker KE, Coyle C, Sen M. Prestwich RJ, et al. Radiat Oncol. 2010 Dec 21;5:121. doi: 10.1186/1748-717X-5-121. Radiat Oncol. 2010. PMID: 21176154 Free PMC article.

6

Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.

Oksuz DC, Prestwich RJ, Carey B, Wilson S, Senocak MS, Choudhury A, Dyker K, Coyle C, Sen M. Oksuz DC, et al. Radiat Oncol. 2011 May 24;6:54. doi: 10.1186/1748-717X-6-54. Radiat Oncol. 2011. PMID: 21609453 Free PMC article.

7

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.

Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M. Prestwich RJ, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27. Int J Radiat Oncol Biol Phys. 2011. PMID: 21620580

8

Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?

Williams GF, Teo MT, Sen M, Dyker KE, Coyle C, Prestwich RJ. Williams GF, et al. Oral Oncol. 2012 May;48(5):434-40. doi: 10.1016/j.oraloncology.2011.11.022. Epub 2011 Dec 29. Oral Oncol. 2012. PMID: 22209648

9

Absent benefit of accelerated concomitant chemoradiotherapy.

Prestwich RJ, Sen M. Prestwich RJ, et al. Lancet Oncol. 2012 Apr;13(4):e136; author reply e136-7. doi: 10.1016/S1470-2045(12)70085-2. Epub 2012 Mar 30. Lancet Oncol. 2012. PMID: 22469117 No abstract available.

10

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma.

Prestwich RJ, Bhatnagar P, Chowdhury FU, Patel CN, Dyker KE, Coyle C, Sen M, Scarsbrook AF. Prestwich RJ, et al. ISRN Oncol. 2012;2012:636379. doi: 10.5402/2012/636379. Epub 2012 Mar 24. ISRN Oncol. 2012. PMID: 22548190 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page